Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage

Keyphrases

• Recombinant Activated Factor VII (rFVIIa) 100%
• Bleeding 18%
• FDA-approved Drugs 18%
• Hemophilia 18%
• Intracranial Hemorrhage 18%
• Bleeding Episodes 18%
• Life-threatening Hemorrhage 18%
• Pediatric 9%
• Necrotizing Enterocolitis 9%
• Etiology 9%
• Clinical Outcomes 9%
• Clinical Improvement 9%
• Mechanism of Action 9%
• Platelets 9%
• Adult Patients 9%
• Clinical Scenarios 9%
• Cardiac Surgery 9%
• Tissue Injury 9%
• Clinical Resolution 9%
• Laboratory Values 9%
• Hemophilia B 9%
• Multiple Causes 9%
• Coagulopathy 9%
• Fresh Frozen Plasma 9%
• Life-threatening Bleeding 9%
• Dose-ranging 9%
• Cryoprecipitate 9%
• Hemophiliacs 9%
• Massive Hemorrhage 9%
• Factor 9 9%
• Average Weight 9%
• Coagulation Defects 9%
• Pulmonary Hemorrhage 9%
• Approved Indication 9%
• Vitamin K Deficiency 9%
• Failed Attempts 9%
• Intra-abdominal Hemorrhage 9%
• Defect Prior 9%
• Hemostatic Drugs 9%

Medicine and Dentistry

• Bleeding 100%
• Factor VII 100%
• Cerebral Hemorrhage 25%
• Coagulopathy 25%
• Haemophilia A 25%
• Platelet 12%
• Hemostat 12%
• Heart Surgery 12%
• Tissue Injury 12%
• Necrotizing Enterocolitis 12%
• Patient with Hemophilia 12%
• Blood Clotting Factor 8 12%
• Factor IX 12%
• Pulmonary Hemorrhage 12%
• Vitamin K Deficiency 12%
• Haemophilia B 12%
• Abdominal Bleeding 12%
• Pediatrics 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Bleeding 100%
• Blood Clotting Factor 7 100%
• Brain Hemorrhage 25%
• Blood Clotting Disorder 25%
• Haemophilia A 25%
• Tissue Injury 12%
• Hemostatic Agent 12%
• Blood Clotting Factor 8 12%
• Lung Hemorrhage 12%
• Blood Clotting Factor 9 12%
• Vitamin K Deficiency 12%
• Abdominal Bleeding 12%
• Necrotizing Enterocolitis 12%
• Haemophilia B 12%